Loss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells ...

A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

A study recently published in Current Molecular Pharmacology has uncovered a novel mechanism by which the long non‑coding RNA ...

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...

Incidence high in HR-negative patients, but there are effective therapies ...

Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.

A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that preoperative radiation ...

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...

Metastatic cancer cell dormancy, wherein disseminated cancer cells (DCCs) persist in a quiescent state before reactivating to fuel metastasis, has emerged as a critical determinant of cancer relapse.

Genomic data should be considered when selecting patients with metastatic NSCLC for MDT, and these results provide evidence that integrating multimodal data to number of metastases may better identify ...